World's Best Scientists 2026 revealed!
Peter L. Lakatos

Peter L. Lakatos

D-Index & Metrics

Medicine

D-Index
93
Citations
42608
World Ranking
10706
National Ranking
427

Overview

Peter L. Lakatos is affiliated with McGill University in Canada and has made extensive contributions in the field of medical research, particularly focused on inflammatory bowel diseases and related areas. The scientist has a significant body of work spanning various topics, subfields, and multiple prestigious publication venues.

Lakatos's research primarily revolves around key topics including:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Eosinophilic Esophagitis
  • Diagnosis and treatment of tuberculosis
  • Biosimilars and Bioanalytical Methods
  • Autoimmune and Inflammatory Disorders
  • Immunodeficiency and Autoimmune Disorders

Their research spans broad fields of study such as Medicine and Biochemistry, Genetics and Molecular Biology. Within these, they have contributed notably to subfields including:

  • Genetics
  • Epidemiology
  • Surgery
  • Immunology
  • Oncology

Peter L. Lakatos has published prolifically, with several recent papers highlighting various aspects of inflammatory bowel disease. Notable recent publications include:

  • "ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment," 2021, Journal of Crohn's and Colitis
  • "ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment," 2021, Journal of Crohn's and Colitis
  • "The Burden of Inflammatory Bowel Disease in Europe in 2020," 2021, Journal of Crohn's and Colitis
  • "Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting," 2020, Gastroenterology
  • "Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study," 2020, The Lancet. Gastroenterology & Hepatology

The scientist frequently collaborates with several peers, including:

  • Talat Bessissow
  • Waqqas Afif
  • Alain Bitton
  • Petra A. Golovics
  • Lóránt Gönczi

Peter L. Lakatos's work appears extensively in specialized journals, with a concentration of publications in:

  • Journal of Crohn's and Colitis
  • Gastroenterology
  • Journal of the Canadian Association of Gastroenterology
  • Journal of Clinical Medicine
  • Inflammatory Bowel Diseases

Best Publications

  • Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

    Dennis M. Black;Pierre D. Delmas;Richard Eastell;Ian R. Reid

  • Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

    L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch

  • The burden of inflammatory bowel disease in Europe.

    Johan Burisch;Tine Jess;Matteo Martinato;Peter L. Lakatos

  • Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

    Angelo Agostoni;Emel Aygören-Pürsün;Karen E. Binkley;Alvaro Blanch

  • The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT)

    Dennis M Black;Ian R Reid;Steven Boonen;Christina Bucci-Rechtweg

  • The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease

    Marcus Harbord;Vito Annese;Stephan R. Vavricka;Matthieu Allez

  • Extraintestinal manifestations of inflammatory bowel disease

    Stephan R. Vavricka;Alain Schoepfer;Michael Scharl;Peter L. Lakatos

  • 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.

    Paolo Gionchetti;Axel Dignass;Silvio Danese;Fernando José Magro Dias

  • European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

    E. F. Stange;S. P. L. Travis;S. Vermeire;W. Reinisch

  • Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

    Peter Laszlo Lakatos

  • Geographical variability and environmental risk factors in inflammatory bowel disease

    Siew C. Ng;Charles N. Bernstein;Morten H. Vatn;Peter Laszlo Lakatos

  • East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

    J. Burisch;N Pedersen;S Cukovic-Cavka;M Brinar

  • Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

    Peter Laszlo Lakatos;Laszlo Lakatos

  • Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.

    David L. Kendler;Fernando Marin;Cristiano A. F. Zerbini;Luis A. Russo

  • Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2-year results from the MOBILE study

    J-Y Reginster;Silvano Adami;Peter Lakatos;Maria Greenwald

  • Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

    Bente L Langdahl;Cesar Libanati;Daria B Crittenden;Michael A Bolognese

  • ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

    Antonino Spinelli;Stefanos Bonovas;Johan Burisch;Torsten Kucharzik

  • Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study

    Laszlo Lakatos;Tunde Pandur;Gyula David;Zsuzsanna Balogh

  • Epidemiology and Diagnosis of Hypoparathyroidism.

    Bart L. Clarke;Edward M. Brown;Michael T. Collins;Harald Jüppner

  • Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality

    Myles Wolf;Miklos Z. Molnar;Miklos Z. Molnar;Ansel P. Amaral;Maria E. Czira

Frequent Co-Authors

Ernest G. Seidman
Ernest G. Seidman McGill University
Pia Munkholm
Pia Munkholm University of Copenhagen
Laurent Peyrin-Biroulet
Laurent Peyrin-Biroulet University of Lorraine
Silvio Danese
Silvio Danese Vita-Salute San Raffaele University
Walter Reinisch
Walter Reinisch Medical University of Vienna
Gerhard Rogler
Gerhard Rogler University of Zurich
Gary L. Norman
Gary L. Norman University of Debrecen
László Gulácsi
László Gulácsi Óbuda University
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine is highly rewarding, but there are also diverse, flexible online options in the healthcare field that can lead to excellent career opportunities. For those interested in nursing, some easiest nursing schools to get into offer accessible admission requirements, making it possible to start your nursing journey with fewer obstacles.

If you want to avoid standardized entrance exams, consider a nursing school that does not require teas test, allowing you to focus on your studies rather than on test preparation. For those interested in the administrative side of healthcare, there are online healthcare administration degree programs that offer flexible, accelerated pathways into management roles.

Billing and coding is another in-demand career path. Explore medical billing and coding schools that accept financial aid if you are seeking roles that combine healthcare and information management. These online degree programs offer varied entry points into healthcare—whether you’re seeking clinical, administrative, or technical positions.

Best Scientists Citing Peter L. Lakatos

Trending Scientists